SAM CHUN DANG PHARM Co., Ltd.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Public
- Established
- 1978-08-28
- Employees
- 408
- Market Cap
- -
- Website
- http://www.scd.co.kr
Clinical Trials
2
Active:1
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 3
1 (50.0%)A Study to Comparing SCD411 and Eylea® in Subjects With Wet Age-related Macular Degeneration (AMD)
Phase 3
Completed
- Conditions
- Wet Age-related Macular DegenerationNeovascular Age-related Macular Degeneration
- Interventions
- First Posted Date
- 2020-07-21
- Last Posted Date
- 2023-10-10
- Lead Sponsor
- Sam Chun Dang Pharm. Co. Ltd.
- Target Recruit Count
- 576
- Registration Number
- NCT04480463
- Locations
- 🇪🇸
SCD Research Site, Zaragoza, Spain
News
No news found